183 related articles for article (PubMed ID: 36414169)
1. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in lifetime and prenatal rodent carcinogenicity bioassays of aspartame.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2023 Jan; 171():113504. PubMed ID: 36414169
[TBL] [Abstract][Full Text] [Related]
2. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in a lifetime rodent carcinogenicity bioassay of sucralose.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2024 Jun; 188():114524. PubMed ID: 38428799
[TBL] [Abstract][Full Text] [Related]
3. Aspartame and cancer - new evidence for causation.
Landrigan PJ; Straif K
Environ Health; 2021 Apr; 20(1):42. PubMed ID: 33845854
[TBL] [Abstract][Full Text] [Related]
4. Aspartame, a bittersweet pill.
Paolini M; Vivarelli F; Sapone A; Canistro D
Carcinogenesis; 2017 Dec; 38(12):1249-1250. PubMed ID: 26912665
[TBL] [Abstract][Full Text] [Related]
5. Updated systematic assessment of human, animal and mechanistic evidence demonstrates lack of human carcinogenicity with consumption of aspartame.
Borghoff SJ; Cohen SS; Jiang X; Lea IA; Klaren WD; Chappell GA; Britt JK; Rivera BN; Choski NY; Wikoff DS
Food Chem Toxicol; 2023 Feb; 172():113549. PubMed ID: 36493943
[TBL] [Abstract][Full Text] [Related]
6. Histological analyses of the Ishii (1981) rat carcinogenicity study of aspartame and comparison with the Ramazzini Institute studies.
Shibui Y; Fujitani S; Iwata H; Lynch B; Roberts A
Regul Toxicol Pharmacol; 2019 Mar; 102():23-29. PubMed ID: 30572082
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and evaluation of aspartame carcinogenicity bioassays using quality criteria.
Haighton L; Roberts A; Walters B; Lynch B
Regul Toxicol Pharmacol; 2019 Apr; 103():332-344. PubMed ID: 29339245
[TBL] [Abstract][Full Text] [Related]
8. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats.
Soffritti M; Belpoggi F; Tibaldi E; Esposti DD; Lauriola M
Environ Health Perspect; 2007 Sep; 115(9):1293-7. PubMed ID: 17805418
[TBL] [Abstract][Full Text] [Related]
9. The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.
Soffritti M; Padovani M; Tibaldi E; Falcioni L; Manservisi F; Belpoggi F
Am J Ind Med; 2014 Apr; 57(4):383-97. PubMed ID: 24436139
[TBL] [Abstract][Full Text] [Related]
10. NTP report on the toxicology studies of aspartame (CAS No. 22839-47-0) in genetically modified (FVB Tg.AC hemizygous) and B6.129-Cdkn2atm1Rdp (N2) deficient mice and carcinogenicity studies of aspartame in genetically modified [B6.129-Trp53tm1Brd (N5) haploinsufficient] mice (feed studies).
National Toxicology Program
Natl Toxicol Program Genet Modif Model Rep; 2005 Oct; (1):1-222. PubMed ID: 18685711
[TBL] [Abstract][Full Text] [Related]
11. Aspartame and Risk of Cancer: A Meta-analytic Review.
Mallikarjun S; Sieburth RM
Arch Environ Occup Health; 2015; 70(3):133-41. PubMed ID: 24965331
[TBL] [Abstract][Full Text] [Related]
12. Lack of potential carcinogenicity for aspartame - Systematic evaluation and integration of mechanistic data into the totality of the evidence.
Wikoff DS; Chappell GA; Fitch S; Doepker CL; Borghoff SJ
Food Chem Toxicol; 2020 Jan; 135():110866. PubMed ID: 31614175
[TBL] [Abstract][Full Text] [Related]
13. Hemolymphoreticular Neoplasias from the Ramazzini Institute Long-term Mice and Rat Studies on Aspartame.
Gnudi F; Panzacchi S; Tibaldi E; Iuliani M; Sgargi D; Bua L; Mandrioli D
Ann Glob Health; 2023; 89(1):43. PubMed ID: 37362827
[TBL] [Abstract][Full Text] [Related]
14. Aspartame Safety as a Food Sweetener and Related Health Hazards.
Shaher SAA; Mihailescu DF; Amuzescu B
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630817
[TBL] [Abstract][Full Text] [Related]
15. Consequences of exposure to carcinogens beginning during developmental life.
Soffritti M; Belpoggi F; Esposti DD; Falcioni L; Bua L
Basic Clin Pharmacol Toxicol; 2008 Feb; 102(2):118-24. PubMed ID: 18226064
[TBL] [Abstract][Full Text] [Related]
16. Aspartame carcinogenic potential revealed through network toxicology and molecular docking insights.
Chen D; Hou X
Sci Rep; 2024 May; 14(1):11492. PubMed ID: 38769413
[TBL] [Abstract][Full Text] [Related]
17. [Important Points at Interpretation ofNongenotoxic-Carcinogenicity Induced by Pesticidesin Rodent Bioassays].
Satoh H; Machino S; Fujii T; Yoshida M; Asano S; Yokoyama Y; Miyajima K
Shokuhin Eiseigaku Zasshi; 2022; 63(1):34-42. PubMed ID: 35264520
[TBL] [Abstract][Full Text] [Related]
18. Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice.
Soffritti M; Belpoggi F; Manservigi M; Tibaldi E; Lauriola M; Falcioni L; Bua L
Am J Ind Med; 2010 Dec; 53(12):1197-206. PubMed ID: 20886530
[TBL] [Abstract][Full Text] [Related]
19. Results of long-term carcinogenicity bioassay on Sprague-Dawley rats exposed to aspartame administered in feed.
Belpoggi F; Soffritti M; Padovani M; Degli Esposti D; Lauriola M; Minardi F
Ann N Y Acad Sci; 2006 Sep; 1076():559-77. PubMed ID: 17119233
[TBL] [Abstract][Full Text] [Related]
20. Commentary: further comments on Mycoplasma pulmonis and lymphoma in bioassays of rats.
Schoeb TR; McConnell EE
Vet Pathol; 2011 Mar; 48(2):420-6. PubMed ID: 20716760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
